| 000 | 01068 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514170626.0 | ||
| 264 | 0 | _c20040322 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a1472-4472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFingleton, Barbara | |
| 245 | 0 | 0 |
_aCMT-3. CollaGenex. _h[electronic resource] |
| 260 |
_bCurrent opinion in investigational drugs (London, England : 2000) _cDec 2003 |
||
| 300 |
_a1460-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xstatistics & numerical data |
| 650 | 0 | 4 |
_aDrugs, Investigational _xchemistry |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
| 650 | 0 | 4 |
_aMatrix Metalloproteinases _xmetabolism |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 650 | 0 | 4 |
_aTetracyclines _xadverse effects |
| 773 | 0 |
_tCurrent opinion in investigational drugs (London, England : 2000) _gvol. 4 _gno. 12 _gp. 1460-7 |
|
| 999 |
_c14486799 _d14486799 |
||